Difference between revisions of "Gallbladder"

Jump to navigation Jump to search
(→‎Xanthogranulomatous cholecystitis: *added pancreatic heterotopia)
Line 190: Line 190:


Notes:
Notes:
*All of the gallbladder should be submitted prior to sign out to exclude non-sampled adenocarcinoma.
*Low grade dysplasia should prompt targeted sampling and review.<ref name=uscap2017_akki/>
*Gallbladders with high grade dysplasia should be [[submitted in total]] to exclude [[gallbladder adenocarcinoma]].<ref name=uscap2017_akki>Akki ''et al.'' (2017) "Detecting Incidental Gallbladder Adenocarcinoma: When to Submit the Entire Gallbladder".  Available at: [http://www.abstracts2view.com/uscap17/view.php?nu=USCAP17L_2016 http://www.abstracts2view.com/uscap17/view.php?nu=USCAP17L_2016]. United States and Canadian Academy of Pathology Annual Meeting. Accessed on: April 9, 2017.</ref>


DDx:
DDx: